ellipticine has been researched along with Angiogenesis, Pathologic in 1 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, J | 1 |
| Lee, HH | 1 |
| Jeong, Y | 1 |
| Yoon, S | 1 |
| An, HJ | 1 |
| Baek, M | 1 |
| Kim, DK | 1 |
| Lee, S | 1 |
1 other study available for ellipticine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Paradoxical Pro-angiogenic Effect of Low-Dose Ellipticine Identified by In Silico Drug Repurposing.
Topics: beta Catenin; Cell Survival; Cells, Cultured; Drug Discovery; Drug Repositioning; Ellipticines; Gene | 2021 |